Neuland Laboratories Beta
Was ist das Beta von Neuland Laboratories?
Beta von Neuland Laboratories Limited ist -0.32
Was ist die Definition von Beta?
BETA gibt an, ob eine Aktie mehr oder weniger schwankungsanfällig ist als der Gesamtmarkt. Ein Beta von weniger als 1 zeigt an, dass die Aktie weniger schwankungsanfällig ist als der Markt, während ein Beta von mehr als 1 anzeigt, dass die Aktie mehr schwankungsanfällig ist. Die Schwankungsanfälligkeit wird als Schwankung des Preises um den Mittelwert gemessen.
Beta is a measure of the risk arising from exposure to general market movements as opposed to idiosyncratic factors. The market portfolio of all investable assets has a beta of exactly 1. A beta below 1 can indicate either an investment with lower volatility than the market, or a volatile investment whose price movements are not highly correlated with the market. A beta greater than one generally means that the asset both is volatile and tends to move up and down with the market. Beta is important because it measures the risk of an investment that cannot be reduced by diversification. It does not measure the risk of an investment held on a stand-alone basis, but the amount of risk the investment adds to an already-diversified portfolio. In the capital asset pricing model, beta risk is the only kind of risk for which investors should receive an expected return higher than the risk-free rate of interest.
Beta von Unternehmen in Health Care Sektor auf BSE im Vergleich zu Neuland Laboratories
Was macht Neuland Laboratories?
Neuland Laboratories Limited manufactures and sells active pharmaceutical ingredients (APIs) in India, Europe, the United States, and internationally. The company's APIs are used in various therapeutic areas, including antiasthmatics, cardiovasculars, antifungal, anticonvulsants, antiemetic, central nervous system, fluoroquinolones, corticosteroids, antipsychotic, antibacterial and anti-parkinson, anti-ulcerants, and prostaglandins. It also provides custom manufacturing solutions, as well as peptide synthesis services. The company was founded in 1984 and is headquartered in Hyderabad, India.
Unternehmen mit beta ähnlich Neuland Laboratories
- BigDish Plc hat Beta von -0.33
- GTN Textiles hat Beta von -0.33
- Lifestyle Global Brands hat Beta von -0.32
- Respiri hat Beta von -0.32
- Vision Values hat Beta von -0.32
- Weaccess Societe Anonyme hat Beta von -0.32
- Neuland Laboratories hat Beta von -0.32
- Wirecard AG hat Beta von -0.32
- Tokyo Gas Co hat Beta von -0.32
- Sunshine 100 China Ltd hat Beta von -0.32
- iCollege hat Beta von -0.32
- Nagreeka Capital & Infrastructure hat Beta von -0.32
- ElectroCore Inc hat Beta von -0.32